Marrone Bio Innovations Inc (MBII)
US57165B1061 - Common Stock
| MRQ (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 9.36M | 19.62M | 15.84M | 6.25M | 18.22M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 12.11M | 13.21M | 10.11M | 5.93M | 2.72M | |||
| Inventories | 10.12M | 8.63M | 6.62M | 8.15M | 8.22M | |||
| Other Current Assets | 1.37M | 1.21M | 1.69M | 1.39M | 970.00K | |||
| Total Current Assets | 32.96M | 42.68M | 34.26M | 21.72M | 30.14M | |||
| Non-Current Assets | ||||||||
| PPE Net | 15.79M | 16.31M | 16.33M | 17.83M | 14.51M | |||
| Goodwill | 6.74M | 6.74M | 6.74M | 6.76M | N/A | |||
| Intangibles | 18.43M | 19.01M | 21.38M | 23.84M | N/A | |||
| Other Non-Current Assets | 2.30M | 2.31M | 2.49M | 2.57M | 1.92M | |||
| Total Non-Current Assets | 43.25M | 44.38M | 46.94M | 51.00M | 16.43M | |||
| TOTAL ASSETS | 76.21M | 87.06M | 81.20M | 72.72M | 46.57M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 24.28M | 25.91M | 9.30M | 3.90M | 2.32M | |||
| Accrued Expenses | 13.79M | 16.23M | 12.66M | 13.38M | 6.87M | |||
| Accounts Payable | 3.36M | 2.69M | 1.90M | 3.38M | 1.69M | |||
| Other Current Liabilities | 280.00K | 360.00K | 370.00K | 430.00K | 440.00K | |||
| Total Current Liabilities | 41.71M | 45.19M | 24.23M | 21.09M | 11.32M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 7.59M | 7.69M | 18.78M | 19.15M | 19.12M | |||
| Other Non-Current Liabilities | 4.04M | 4.52M | 6.78M | 8.93M | 3.19M | |||
| Total Non-Current Liabilities | 11.63M | 12.21M | 25.56M | 28.07M | 22.31M | |||
| TOTAL LIABILITIES | 53.34M | 57.40M | 49.79M | 49.16M | 33.63M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -364.97M | -357.37M | -340.82M | -320.65M | -283.47M | |||
| Additional Paid In Capital | 387.84M | 387.02M | 372.23M | 344.21M | 296.41M | |||
| Common Shares | N/A | 1.00K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 182.28M | 182.22M | 167.48M | 139.53M | 110.69M | |||
| Tangible Book Value per Share | -0.01 | 0.02 | 0.02 | -0.05 | 0.12 | |||
| Total Shareholders' Equity | 22.87M | 29.65M | 31.41M | 23.56M | 12.94M | |||
| TOTAL LIABILITIES AND EQUITY | 76.21M | 87.06M | 81.20M | 72.72M | 46.57M | |||
| Statistics | ||||||||
| Debt/Equity | 0.33 | 0.26 | 0.60 | 0.81 | 1.48 | |||
| Current Ratio | 0.79 | 0.94 | 1.41 | 1.03 | 2.66 | |||
| Return On Assets (ROA) | -27.42% | -19.01% | -24.84% | -51.13% | -43.40% | |||
| Return On Equity (ROE) | -91.39% | -55.82% | -64.22% | -157.81% | -156.18% | |||
All data in USD